PRESS RELEASE

from Natus Medical Incorporated

Natus expands availability to expert-level review of EEG with global launch of autoSCORE AI analysis tool

EQS-News: Natus Medical Incorporated / Key word(s): Product Launch
Natus expands availability to expert-level review of EEG with global launch of autoSCORE AI analysis tool

05.03.2026 / 16:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


MIDDLETON, Wis., March 5, 2026 /PRNewswire/ -- Natus Medical Incorporated has announced the global launch of the autoSCORE™ analysis tool, spreading the availability of the first artificial-intelligence model capable of automatic and comprehensive clinical EEG interpretations while providing accuracy on par with medical experts.

With its introduction to the United States market in August 2024 for routine EEG studies, U.S. neuro care teams became the first to experience the benefits of autoSCORE, which alleviated the demands on clinical resources and staff through a deep-learning model developed in Norway by Holberg EEG and trained on 30,000 expertly labeled EEG recordings. Offered exclusively with Natus NeuroWorks software, autoSCORE is FDA 510(k) cleared for an expanded indication to include routine EEG, LTM and Ambulatory EEG studies. It has also received the CE mark for European and other international markets.

"Developing the first AI model capable of interpreting clinical EEGs at the level of the world's top experts marks a defining moment for both Natus and the field of neurodiagnostics," said Chris Landon, CEO of Natus Neuro. "Now, we're proud to bring this breakthrough innovation to healthcare providers globally – advancing our mission to expand patient access and deliver life-changing outcomes through cutting-edge neuro solutions."

Early adopters welcomed the confidence provided by the ability of autoSCORE to go beyond traditional spike and seizure detectors, assessing multiple clinically relevant abnormalities and providing study-level assessments to inform healthcare providers if an EEG study is normal or abnormal. They also found comfort in its closed AI model, which ensures consistency and security.

"Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system," said Dr. Ram Mohan Sankaraneni, a board-certified neurologist and fellow of the American Epilepsy Society and the American Academy of Neurology. "(autoSCORE) is a reliable colleague that can provide a second opinion... a powerful pathway to faster interventions."

Visual EEG review is considered the gold standard for determining abnormalities, but it can strain department resources. The AI-enabled autoSCORE application is designed to allow teams to more efficiently and consistently perform EEG data analysis.

ABOUT NATUS

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain and neural pathways. The best-in-class Natus solutions, including service, field support and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information on Natus, visit natus.com/neuro.

CONTACT INFORMATION:
Lisa Schuler
Phone: +1 612 528-1332
Email: lisa.schuler@natus.com

Dr. Ram Mohan Sankaraneni declares the Natus autoSCORE analysis tool a powerful pathway to faster interventions.

 

Natus Color Logo

Video - https://mma.prnewswire.com/media/2926890/autoSCORE_Global_Chris_Landon.mp4 
Photo - https://mma.prnewswire.com/media/2926889/autoSCORE_Sankaraneni_Quote.jpg 
Logo - https://mma.prnewswire.com/media/2477077/5838090/Natus_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/natus-expands-availability-to-expert-level-review-of-eeg-with-global-launch-of-autoscore-ai-analysis-tool-302705444.html

rt.gif?NewsItemId=EN02217&Transmission_Id=202603051023PR_NEWS_EURO_ND__EN02217&DateId=20260305


05.03.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2286686  05.03.2026 CET/CEST

See all Natus Medical Incorporated news